QURE:NASDAQ
Uniqure NV
$44.86
arrow_downward
-2.96%(-1.37) 1D
$44.50
arrow_downward
-0.80% (-0.36)bedtimeAfter hours
Closed: Sep 3, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QURE...
Open
$45.50
High
$46.03
Low
$44.03
Mkt. cap
3.11B
Avg. vol.
1.34M
Volume
0.00
52-wk high
$71.50
52-wk low
$8.73
EPS
-$4.05
Beta
0.94
Shares outstanding
69.37M
No. of employees
221
Open
$45.50
High
$46.03
Low
$44.03
Mkt. cap
3.11B
Avg. vol.
1.34M
Volume
0.00
52-wk high
$71.50
52-wk low
$8.73
EPS
-$4.05
Beta
0.94
Shares outstanding
69.37M
No. of employees
221
News stories
From web sources and news partners
Zacks
·
16 hours ago
QURE Submits Application for Gene Therapy for Huntington's Disease
Yahoo Finance
·
1 day ago
QURE Stock Fades After AMT-130 filing — But William Blair Sees 58% Upside
Investor's Business Daily
·
1 day ago
UniQure's Embattled Huntington's Gene Therapy Clears A Key Hurdle
Profile
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
About Uniqure NV